Table 1.
M/F | Pathology | References | |||
---|---|---|---|---|---|
Embryonic stem cell lines | |||||
H1 | M | Normal | 29,73 | ||
H9 | F | Normal | 14,19,24,29,45,49,62,65,68,69,73,83 | ||
UM77-2 | F | Normal | 54 | ||
SEEC3 | M | Normal | 84 | ||
Envy (hES3) | F | Normal | 44,69 | ||
Man11 | F | Normal | 74 | ||
Man13 | M | Normal | 74 | ||
HUES1 | F | Normal | 74 | ||
iPSC lines | M/F | Age | Reprogramming | Source | |
WTC-11 | M | Adult | Episomal | Skin fibroblast | 19,49,85 |
CRL1502-c32 | F | <1 y | Episomal | Skin fibroblast | 15,44,47,81,86 |
CRL1502.3 | F | <1 y | Episomal | Skin fibroblast | 69 |
IMR90-1 | F | Fetal | Lentivirus | Lung fibroblast | 83 |
IMR90-4 | F | Fetal | Lentivirus | Lung fibroblast | 87 |
BCRTi004-A | F | Adult | Sendai virus | Urinary | 87 |
BCRTi005-A | F | Adult | Sendai virus | Urinary | 87 |
201B7 | F | Adult | Lentivirus | Skin fibroblast | 18,53 |
RN7 | N/A | Adult | Sendai virus | Peripheral blood | 53 |
BJFF.6 | M | <1 y | Sendai virus | Fibroblast | 68 |
MANZ-2-2 | F | Adult | Sendai virus | Fibroblast | 15 |
BJ RiPS | M | mRNA | Fibroblast | 15 | |
LUMC0099iCTRL04 | F | Adult | mRNA | Skin fibroblast | 44 |
Patient/disease cell lines | Reprogramming | Source | Pathology | Citation | |
Nephrin | Sendai virus | Skin fibroblasts | E725D nephrin | 52 | |
IFT140 | Episomal | Fibroblast | c.634G>A and c.2176C>G | 60 | |
IFT140 corrected | CRISPR/Cas9 | 60 | |||
ARPKD | Episomal | Fibroblast | c.11630delT | 29 | |
ARPKD corrected | CRISPR/Cas9 | 29 | |||
PKD1−/− | CRISPR/Cas9 | H9 | PKD1 deletion | 24,88 | |
PKD2−/− | CRISPR/Cas9 | H9 | PKD2 deletion | 24,88 | |
PODXL−/− | CRISPR/Cas9 | H9 | Podocalyxin deficient | 49,88 |
Abbreviations: M/F, male/female; mRNA, messenger RNA.